Results

Total Results: 2,078 records

Showing results for "drugs".

201. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     January 06, 2017 - The largest trials in ALS on drugs are generally done in populations of hundreds. … They're tracking some of the side effects from their drugs and symptoms. … They're not fun drugs to take. … their medication because they're better understanding about what to expect and what's caused by drugs … and what's not caused by drugs.

202. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/protocol
     March 01, 2019 - most common forms of pharmacologic treatment for pain include opioids, nonsteroidal anti-inflammatory drugs … (NSAIDs), acetaminophen, topical formulations of drugs such as lidocaine, and other drugs such as antiseizure … Interventions: Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen, muscle … : Dronabinol (THC), Nabilone (similar to THC)   Injectable preparations, including biologic drugs … Supplemental Evidence And Data for Systematic review (SEADS): Manufacturers of included drugs will be

203. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - most common forms of pharmacologic treatment for pain include opioids, nonsteroidal anti- inflammatory drugs … (NSAIDs), acetaminophen, topical formulations of drugs such as lidocaine, and other drugs such as antiseizure … Interventions: • Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen, muscle … , triptans) • Salicylates (topical and oral) • Topical menthol preparations • Disease-modifying drugs … Supplemental Evidence And Data for Systematic review (SEADS): Manufacturers of included drugs will be

204. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - dossiers from five pharmaceutical companies (AstraZeneca, Eli Lilly, GlaxoSmithKline, Warner Chilcott Pharmaceuticals … • Mirtazapine led to higher weight gains than comparator drugs. … The incidence was 8 percent (95% CI, 3 to 11 percent) higher than with comparator drugs. … The strength of evidence that trazodone leads to higher rates of somnolence than comparator drugs is … Evidence of high and moderate strength supports some differences among individual drugs with respect

205. Medicare Prescription Drug Coverage | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/medicare-prescription-drug-coverage/

206. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
     November 01, 2016 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the single topic for which (1) preliminary phase III data for drugs were … estrogen to partially restore estrogen levels, may also be needed while patients are receiving these drugs

207. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
     November 01, 2016 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the single topic for which (1) preliminary phase III data for drugs were … estrogen to partially restore estrogen levels, may also be needed while patients are receiving these drugs

208. Treatment of Depression During Pregnancy and the Postpartum Period | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/depression-pregnancy-postpartum/research-protocol
     March 29, 2013 - Coadministration of other psychoactive drugs, specifically, antipsychotics, antianxiety agents (e.g., … benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs. … Drugs not listed below will not be included (e.g., monoamine oxidase inhibitors). Table 1. … The drugs listed above in Table 1 when compared with each other.

209. depression-pregnancy-postpartum-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
     March 29, 2013 - Coadministration of other psychoactive drugs, specifically, antipsychotics, antianxiety agents (e.g … ., benzodiazepines), and drugs for insomnia? … Interventions Interventions include commonly used antidepressant drugs. … Drugs not listed below will not be included (e.g., monoamine oxidase inhibitors). Table 1. … • The drugs listed above in Table 1 when compared with each other.

210. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Vertex Pharmaceuticals, Cystic Fibrosis Foundation. … Vertex Pharmaceuticals Incorporated, Cystic Fibrosis Foundation. … Pricing for orphan drugs: will the market bear what society cannot? … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

211. Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/survival-quality/research
     April 12, 2013 - from any cause, has recently become an endpoint of considerable interest in the study of new oncology drugs … The literature search for KQ2 included terms for drugs approved by one or more regulatory agencies on

212. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Autism treatments and drugs. [internet].

213. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
     January 01, 2012 - They are extended-release exenatide for injection (Bydureon ™ , Amylin Pharmaceuticals, Inc., San … exenatide, leaving sole development responsibility to Amylin Pharmaceuticals. … No major hypoglycemia events occurred. 47 In July 2011, Amylin Pharmaceuticals, Eli Lilly, and … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2012 Feb 20]. [4 p]. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27. 11 p.

214. Despite steadily increasing health care expenditures in the United States, improved health outcomes and quality remain elusive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_slutsky_comparing_medical_interventions.pdf
     November 01, 2008 - independent agencies that inform health care decisionmaking through systematic reviews of technologies, pharmaceuticals … Care (IQWiG) in Germany, the Haute Autorité de Santé (HAS) in France, and the Canadian Agency for Drugs … research with a focus on the outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … Reviews builds on nearly 10 years of experience doing systematic reviews of diverse topics, including drugs … For example, the results of trials comparing the abilities of different oral diabetes drugs to control

215. Despite steadily increasing health care expenditures in the United States, improved health outcomes and quality remain elusive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-interventions-comparing_methods.pdf
     November 01, 2008 - independent agencies that inform health care decisionmaking through systematic reviews of technologies, pharmaceuticals … Care (IQWiG) in Germany, the Haute Autorité de Santé (HAS) in France, and the Canadian Agency for Drugs … research with a focus on the outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … Reviews builds on nearly 10 years of experience doing systematic reviews of diverse topics, including drugs … For example, the results of trials comparing the abilities of different oral diabetes drugs to control

216. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http://www.cesar.umd.edu/cesar/drugs/ketamine.pdf http … J Psychoactive Drugs. 2015 Sep-Oct;47(4):276- 85. … Rochester (MI): JHP Pharmaceuticals, LLC; 2012 Mar 01 [accessed 2012 Mar 15]. [6 p]. … Rochester (MI): JHP Pharmaceuticals, LLC; 2011 Jun. 4 p.

217. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

218. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

219. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

220. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the